Millennium Management LLC lifted its stake in Cronos Group Inc. (NASDAQ:CRON - Free Report) by 23.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 840,374 shares of the company's stock after purchasing an additional 161,163 shares during the period. Millennium Management LLC owned approximately 0.22% of Cronos Group worth $1,698,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. D. E. Shaw & Co. Inc. raised its position in Cronos Group by 27.8% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 154,160 shares of the company's stock worth $310,000 after acquiring an additional 33,560 shares during the last quarter. Aquatic Capital Management LLC acquired a new position in Cronos Group during the fourth quarter worth about $148,000. Kerrisdale Advisers LLC raised its position in Cronos Group by 2.3% during the fourth quarter. Kerrisdale Advisers LLC now owns 468,786 shares of the company's stock worth $947,000 after acquiring an additional 10,539 shares during the last quarter. Tower Research Capital LLC TRC raised its position in Cronos Group by 140.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company's stock worth $28,000 after acquiring an additional 8,019 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Cronos Group by 5.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,753,055 shares of the company's stock worth $5,561,000 after acquiring an additional 132,536 shares during the last quarter. Institutional investors and hedge funds own 8.71% of the company's stock.
Cronos Group Price Performance
CRON traded up $0.07 during midday trading on Friday, reaching $1.98. 4,999,841 shares of the company's stock were exchanged, compared to its average volume of 1,332,739. The stock has a market capitalization of $763.13 million, a PE ratio of -15.23, a P/E/G ratio of 1.74 and a beta of 1.06. The business's 50-day moving average price is $1.88 and its 200 day moving average price is $1.93. Cronos Group Inc. has a 1-year low of $1.60 and a 1-year high of $2.56.
Cronos Group (NASDAQ:CRON - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.01 by $0.01. The company had revenue of $33.62 million during the quarter, compared to analysts' expectations of $45.44 million. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 2.56%. As a group, analysts expect that Cronos Group Inc. will post -0.03 EPS for the current fiscal year.
About Cronos Group
(
Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Further Reading
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
